Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 6 (2009), Issue 6 (June)

1. Somatic mitochondrial mutations in pilocytic astrocytoma.
   Cancer Genet Cytogenet, 192(1): 30-5. [Abstract] [Full-text]
2. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers.
   Int J Cancer, 125(2): 353-5. [Abstract] [Full-text]
3. Frameless image-guided intracranial stereotactic radiosurgery: clinical outcomes for brain metastases.
   Int J Radiat Oncol Biol Phys, 74(3): 702-6. [Abstract] [Full-text]
4. White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors.
   Int J Radiat Oncol Biol Phys, 74(3): 837-43. [Abstract] [Full-text]
5. Evaluation of different score index for predicting prognosis in gamma knife radiosurgical treatment for brain metastasis.
   Int J Radiat Oncol Biol Phys, 74(3): 707-13. [Abstract] [Full-text]
6. Target definition by C11-methionine-PET for the radiotherapy of brain metastases.
   Int J Radiat Oncol Biol Phys, 74(3): 714-22. [Abstract] [Full-text]
7. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
   Biomaterials, 30(23): 3986-95. [Abstract] [Full-text]
8. Exposure to farm crops, livestock, and farm tasks and risk of glioma: the Upper Midwest Health Study.
   Am J Epidemiol, 169(12): 1479-91. [Abstract] [Full-text]
9. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model.
   Cancer Lett, 281(1): 53-63. [Abstract] [Full-text]
10. Silibinin inhibits glioma cell proliferation via Ca2+/ROS/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo.
    Neurochem Res, 34(8): 1479-90. [Abstract] [Full-text]
11. Zinc induces expression of the BH3-only protein PUMA through p53 and ERK pathways in SH-SY5Y neuroblastoma cells.
    Neurochem Res, 34(8): 1498-506. [Abstract] [Full-text]
12. Maternal occupational exposure to extremely low frequency magnetic fields and the risk of brain cancer in the offspring.
    Cancer Causes Control, 20(6): 945-55. [Abstract] [Full-text]
13. Familial pituitary adenomas.
    J Intern Med, 266(1): 5-18. [Abstract] [Full-text]
14. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Pediatr Blood Cancer, 53(2): 156-61. [Abstract] [Full-text]
15. Wilms tumor, AML and medulloblastoma in a child with cancer prone syndrome of total premature chromatid separation and Fanconi anemia.
    Pediatr Blood Cancer, 53(2): 208-10. [Abstract] [Full-text]
16. Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma.
    Pediatr Blood Cancer, 53(2): 136-44. [Abstract] [Full-text]
17. Slow-growing craniopharyngioma masquarading as early-onset eating disorder: two cases.
    Int J Eat Disord, 42(5): 475-8. [Abstract] [Full-text]
18. Automated brain tumor segmentation using spatial accuracy-weighted hidden Markov Random Field.
    Comput Med Imaging Graph, 33(6): 431-41. [Abstract] [Full-text]
19. Monte Carlo and analytical calculations of dose distributions in craniopharyngioma cysts treated with radiocolloids containing 32P or 186Re.
    Appl Radiat Isot, 67(9): 1697-701. [Abstract] [Full-text]
20. The analgesic properties of scalp infiltrations with ropivacaine after intracranial tumoral resection.
    Anesth Analg, 109(1): 240-4. [Abstract] [Full-text]
21. Expression of extracellular matrix molecules in brain metastasis.
    J Surg Oncol, 100(1): 65-8. [Abstract] [Full-text]
22. End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.
    J Clin Oncol, 27(18): 2905-8. [Abstract] [Full-text]
23. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Acta Radiol, 50(6): 682-9. [Abstract] [Full-text]
24. Rad51 protein expression and survival in patients with glioblastoma multiforme.
    Int J Radiat Oncol Biol Phys, 74(4): 1251-5. [Abstract] [Full-text]
25. Stereotactic radiotherapy of intracranial tumors: a comparison of intensity-modulated radiotherapy and dynamic conformal arc.
    Int J Radiat Oncol Biol Phys, 74(4): 1018-26. [Abstract] [Full-text]
26. Development of dose-volume relation model for gamma knife surgery of non-skull base intracranial meningiomas.
    Int J Radiat Oncol Biol Phys, 74(4): 1027-32. [Abstract] [Full-text]
27. A novel functional polymorphism, 16974 A/C, in the interleukin-12-3' untranslated region is associated with risk of glioma.
    DNA Cell Biol, 28(7): 335-41. [Abstract] [Full-text]
28. Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.
    Endocrinology, 150(7): 3177-85. [Abstract] [Full-text]
29. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.
    Radiology, 252(1): 182-9. [Abstract] [Full-text]
30. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.
    Cancer, 115(13): 2930-8. [Abstract] [Full-text]
31. Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study.
    Eur J Endocrinol, 161(1): 27-35. [Abstract] [Full-text]
32. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma.
    Eur J Endocrinol, 161(1): 201-6. [Abstract] [Full-text]
33. Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
    Cancer, 115(13): 2964-70. [Abstract] [Full-text]
34. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Cancer, 115(13): 2956-63. [Abstract] [Full-text]
35. Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment.
    Eur J Endocrinol, 161(1): 163-9. [Abstract] [Full-text]
36. Spontaneous ovarian hyperstimulation syndrome and pituitary adenoma: incidental pregnancy triggers a catastrophic event.
    Fertil Steril, 92(1): 390.e1-3. [Abstract] [Full-text]
37. Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments.
    Eur J Endocrinol, 161(1): 37-42. [Abstract] [Full-text]
38. Dual-color fluorescence imaging in a nude mouse orthotopic glioma model.
    J Neurosci Methods, 181(2): 178-85. [Abstract] [Full-text]
39. Down-regulation of 67LR reduces the migratory activity of human glioma cells in vitro.
    Brain Res Bull, 79(6): 402-8. [Abstract] [Full-text]
40. Chemotherapeutic drug transport to brain tumor.
    J Control Release, 137(3): 203-10. [Abstract] [Full-text]
41. Primary intracranial leiomyosarcoma: a case report and review of the literature.
    Childs Nerv Syst, 25(8): 1013-7. [Abstract] [Full-text]
42. Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.
    Lung Cancer, 65(2): 198-203. [Abstract] [Full-text]
43. Quality of life in patients with pituitary tumors.
    Curr Opin Endocrinol Diabetes Obes, 16(4): 299-303. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.